1. Camptothecin's journey from discovery to WHO Essential Medicine: fifty years of promise;Khaiwa;Eur. J. Med. Chem.,2021
2. Camptothecin-based prodrug nanomedicines for cancer therapy;Jiang;Nanoscale,2023
3. Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?;Li;Am. J. Cancer Res.,2017
4. Camptothecin loaded nano-delivery systems in the cancer therapeutic domains: a critical examination of the literature;Alshammari;J. Drug Deliv. Sci. Technol.,2023
5. Safe approaches for camptothecin delivery: structural analogues and nanomedicines;Botella;J. Control. Release,2017